Evaluation of the effectiveness of the FOCUS ADHD App in monitoring adults with attention-deficit/hyperactivity disorder

被引:3
作者
Carvalho, Luiz Roberto [1 ]
Haas, Leticia M. [2 ]
Zeni, Gregory [3 ,4 ]
Victor, Marcelo M. [3 ,4 ]
Techele, Stefania P. [3 ,4 ]
Castanho, Julia Marrone [3 ,4 ]
Coimbra, Isabel Meneghetti [3 ,4 ]
de Sousa, Anthony de Freitas [3 ,4 ]
Ceretta, Nathalia [3 ,4 ]
Garrudo, Alia [5 ]
Grevet, Eugenio Horacio [3 ,4 ]
Rohde, Luis Augusto [3 ,4 ,6 ,7 ]
机构
[1] Fac Med Sao Paulo, Inst Psychiat, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Psychiat, Lab Interdisciplinar Neurociencias Clin LiNC, Sao Paulo, Brazil
[3] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Attent Deficit Hyperact Program, Porto Alegre, Brazil
[4] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Dev Psychiat Program, Porto Alegre, Brazil
[5] Univ Sao Paulo, Inst Math & Stat, Sao Paulo, Brazil
[6] UniEduK, Med Council, Sao Paulo, Brazil
[7] Natl Inst Dev Psychiat, Ctr Res & Innovat Mental Hlth, Sao Paulo, Brazil
关键词
adherence; attention-deficit; hyperactivity disorder; digital; discount; mobile app; DEFICIT HYPERACTIVITY DISORDER; SIGNIFICANT OTHERS PEGASUS; PSYCHOEDUCATIONAL GROUPS; ADHERENCE; METAANALYSIS; MEDICATIONS; PREVALENCE; ENGAGEMENT;
D O I
10.1192/j.eurpsy.2023.2422
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundThe current investigation assessed a) the performance of the FOCUS ADHD mobile health application (App) in increasing pharmacological treatment adherence and improving patients' knowledge of attention-deficit/hyperactivity disorder (ADHD) and b) the impact of implementing a financial incentive for using the App (i.e., a discount on medication). MethodsIn a randomized, blind, parallel-group clinical trial, 73 adults diagnosed with ADHD were allocated into three groups for 3 months: a) Pharmacological treatment as usual (TAU); b) TAU and the App (App Group); and c) TAU and the App + a commercial discount on the purchase of medication prescribed for ADHD treatment (App + Discount Group). ResultsThere was no significant difference in mean treatment adherence between groups, assessed as a medication possession ratio (MPR). However, the App + Discount Group exhibited greater medication intake registrations compared with the App Group during the initial phase of the trial. The financial discount also produced a 100% App adoption rate. App use did not increase ADHD knowledge, though knowledge scores were high at baseline. The usability and quality of the App were rated favorably. ConclusionsThe FOCUS ADHD App achieved a high adoption rate and positive evaluations by users. Use of the App did not increase adherence to treatment as measured by MPR, but, for App users, the addition of a financial incentive to use the App produced an increase in treatment adherence in terms of medication intake registrations. The present results offer encouraging data for combining incentives with mobile digital health solutions to positively impact treatment adherence in ADHD.
引用
收藏
页数:9
相关论文
共 61 条
[61]  
Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc